Status:
UNKNOWN
Artificial Intelligence in Mental Illness Diagnosis and Treatment
Lead Sponsor:
Shanghai Mental Health Center
Conditions:
Artificial Intelligence
Mental Illness
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
To improve the quality of mental health services, we will develop a robot that includes disease screening, diagnosis, treatment, and follow-up. The effectiveness of robots will be verified in a prospe...
Detailed Description
Anxiety disorder is the most common mental disorder in the world. The lifetime prevalence of anxiety disorder in China is as high as 7.6%, but the treatment rate is less than 30%, and the standard tre...
Eligibility Criteria
Inclusion
- Community high-risk groups and institutional groups.
- According to the ICD-11 diagnostic guidelines of anxiety-related disorders, depression-related disorders, addiction-related disorders, compulsive-related disorders diagnosis,
- age 18-60 years old,
- skilled in the operation of computers or smartphones,
- language, reading ability is normal,
- willing to participate in the project and sign informed consent study.
Exclusion
- The symptoms of mental illness are severe and require hospitalization, or the patient is unable to complete the required assessment examination and treatment.
- Those who have a higher risk of self-injury or suicide.
- People with severe physical illness, central system disease, or substance abuse.
- Receive physical therapy at the same time.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT04515173
Start Date
April 1 2021
End Date
December 1 2023
Last Update
March 22 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.